Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

BANCA MEDIOLANUM S.P.A.

(BMED)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Banca Mediolanum S.p.A. : The technical configuration is positive

11/17/2021 | 03:15am EST
long trade
Stop-loss triggered
Entry price : 9.15€ | Target : 10.38€ | Stop-loss : 8.56€ | Potential : 13.44%
Banca Mediolanum S.p.A.'s shares display attractive technical aspects to anticipate a comeback of the underlying trend.
Investors have an opportunity to buy the stock and target the € 10.38.
Banca Mediolanum S.p.A. : Banca Mediolanum S.p.A. : The technical configuration is positive
Strengths
  • Before interest, taxes, depreciation and amortization, the company's margins are particularly high.
  • Margins returned by the company are among the highest on the stock exchange list. Its core activity clears big profits.
  • Thanks to a sound financial situation, the firm has significant leeway for investment.
  • The company is one of the best yield companies with high dividend expectations.
  • Over the past year, analysts have regularly revised upwards their sales forecast for the company.
  • Analysts have consistently raised their revenue expectations for the company, which provides good prospects for the current and next years in terms of revenue growth.
  • For the past year, analysts covering the stock have been revising their EPS expectations upwards in a significant manner.
  • Analysts covering this company mostly recommend stock overweighting or purchase.
  • Over the past four months, analysts' average price target has been revised upwards significantly.
  • The opinion of analysts covering the stock has improved over the past four months.
  • There is high visibility into the group's activities for the coming years. Outlooks on future revenues from analysts covering the equity remain similar. Such hardly dispersed estimates support highly predictable sales for the current and upcoming fiscal years.

Weaknesses
  • The company's currently anticipated earnings per share (EPS) growth for the next few years is a notable weakness.

ę MarketScreener.com 2021

Disclaimer: The information, charts, data, views, or comments provided by SURPERFORMANCE SAS are intended for investors who have the necessary knowledge and experience to understand and appreciate the information contained within. These items are disseminated for personal reference only. They do not constitute an offer or solicitation to buy or sell financial products or services, nor an investment advice.
The use of the information disseminated takes place under the investor's sole responsibility, without recourse against SURPERFORMANCE SAS. SURPERFORMANCE SAS will not be liable, whether in contract, in tort, under any warranty, for errors, omissions, improper investments, or adverse evolution of markets.

Financials
Sales 2021 2 249 M 2 551 M 2 551 M
Net income 2021 646 M 732 M 732 M
Net cash 2021 54,4 M 61,6 M 61,6 M
P/E ratio 2021 10,7x
Yield 2021 7,20%
Capitalization 6 517 M 7 390 M 7 392 M
EV / Sales 2021 2,87x
EV / Sales 2022 2,77x
Nbr of Employees 3 174
Free-Float 32,8%
Upcoming event on BANCA MEDIOLANUM S.P.A.
02/14/22
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 12
Last Close Price 8,85 €
Average target price 10,24 €
Spread / Average Target 15,7%
EPS Revisions
Managers and Directors
Massimo Antonio Doris Chief Executive Officer, MD & Director
Giovanni Pirovano Chairman
Anna Eugenia Maria Omarini Independent Director
Mario Notari Independent Director
Francesco Maria Frasca Independent Director
Sector and Competitors